Viewing Study NCT03218969


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-01-07 @ 12:31 AM
Study NCT ID: NCT03218969
Status: UNKNOWN
Last Update Posted: 2018-07-24
First Post: 2017-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
Sponsor: William Ondo, MD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-18
Start Date Type: ACTUAL
Primary Completion Date: 2018-09-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2018-10-15
Completion Date Type: ESTIMATED
First Submit Date: 2017-04-21
First Submit QC Date: None
Study First Post Date: 2017-07-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-20
Last Update Post Date: 2018-07-24
Last Update Post Date Type: ACTUAL